JP2024506667A5 - - Google Patents

Info

Publication number
JP2024506667A5
JP2024506667A5 JP2023548816A JP2023548816A JP2024506667A5 JP 2024506667 A5 JP2024506667 A5 JP 2024506667A5 JP 2023548816 A JP2023548816 A JP 2023548816A JP 2023548816 A JP2023548816 A JP 2023548816A JP 2024506667 A5 JP2024506667 A5 JP 2024506667A5
Authority
JP
Japan
Prior art keywords
group
substituent
compound
compound according
atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023548816A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024506667A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2022/050206 external-priority patent/WO2022170438A1/en
Publication of JP2024506667A publication Critical patent/JP2024506667A/ja
Publication of JP2024506667A5 publication Critical patent/JP2024506667A5/ja
Pending legal-status Critical Current

Links

JP2023548816A 2021-02-12 2022-02-11 多置換シロシビン誘導体およびその使用方法 Pending JP2024506667A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163149001P 2021-02-12 2021-02-12
US63/149,001 2021-02-12
US202163247881P 2021-09-24 2021-09-24
US63/247,881 2021-09-24
PCT/CA2022/050206 WO2022170438A1 (en) 2021-02-12 2022-02-11 Multi-substituent psilocybin derivatives and methods of using

Publications (2)

Publication Number Publication Date
JP2024506667A JP2024506667A (ja) 2024-02-14
JP2024506667A5 true JP2024506667A5 (enExample) 2025-02-19

Family

ID=82838865

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023548816A Pending JP2024506667A (ja) 2021-02-12 2022-02-11 多置換シロシビン誘導体およびその使用方法

Country Status (9)

Country Link
US (4) US11918594B2 (enExample)
EP (1) EP4291549A4 (enExample)
JP (1) JP2024506667A (enExample)
KR (1) KR20230157342A (enExample)
AU (1) AU2022218921A1 (enExample)
CA (1) CA3208152A1 (enExample)
IL (1) IL305125A (enExample)
MX (1) MX2023009491A (enExample)
WO (1) WO2022170438A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11312684B1 (en) 2021-02-10 2022-04-26 Eleusis Therapeutics Us, Inc. Pharmaceutically acceptable salts of psilocin and uses thereof
CA3219577A1 (en) * 2021-05-27 2022-12-01 Nicholas Stuart William MILNE Methods for producing tryptamine derivatives.
WO2023168023A1 (en) 2022-03-04 2023-09-07 Reset Pharmaceuticals, Inc. Co-crystals or salts comprising psilocin
GB202315025D0 (en) * 2023-09-29 2023-11-15 Psylink Uab Production and medical use of psilocybin and related compounds
WO2025099444A1 (en) * 2023-11-09 2025-05-15 Beckley Psytech Limited N-Acetylserotonin (NAS) Analogues

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3182071A (en) * 1961-06-27 1965-05-04 Warner Lambert Pharmaceutical Acylated indole derivatives
US4803218A (en) * 1982-09-29 1989-02-07 Mcneilab, Inc. 3-aminoalkyl-1H-indole-5-urea and amide derivatives
DK1859798T3 (en) * 2001-03-29 2016-03-21 Lilly Co Eli N- (2-arylethyl) -BENZYLAMINER as antagonists of 5-HT6 receptor
ATE553190T1 (de) * 2006-02-22 2012-04-15 Brain Biotechnology Res & Information Network Ag Neue halogenase
US10138205B2 (en) * 2015-02-19 2018-11-27 University Of Florida Research Foundation, Incorporated Artificial self-sufficient cytochrome P450s
KR101934048B1 (ko) * 2017-03-09 2019-03-26 고려대학교 산학협력단 플라빈-의존형 할로게나아제 및 이를 이용한 할로겐화 인돌 화합물의 제조방법
US11591627B2 (en) * 2018-03-21 2023-02-28 University Of Florida Research Foundation, Incorporated Modified bacteria for production of nitroaromatics
CA3132731A1 (en) * 2019-03-07 2020-09-10 University Of Padova Compositions and methods of use comprising substances with neural plasticity actions administered at non-psychedelic/psychotomimetic dosages and formulations
WO2021226416A1 (en) * 2020-05-08 2021-11-11 Psilera Inc. Novel compositions of matter and pharmaceutical compositions
WO2022047583A1 (en) * 2020-09-02 2022-03-10 Magicmed Industries Inc. Nitrated psilocybin derivatives and use thereof for modulating 5-ht2a receptor and for treating a psychiatric disorder
WO2022115944A1 (en) * 2020-12-01 2022-06-09 Magicmed Industries Inc. Carboxylated psilocybin derivatives and methods of using

Similar Documents

Publication Publication Date Title
JP2024506667A5 (enExample)
AU748087B2 (en) Anti-viral pyrimidine derivatives
RU2136692C1 (ru) Уреидопроизводные нафталинфосфоновых кислот или их фармацевтически приемлемые соли и фармацевтическая композиция на их основе
JP6031122B2 (ja) 抗微生物療法のための三環式ホウ素化合物
HU182597B (en) Process for preparing 5-substituted 1-/2'-deoxy-2'-substituted-beta-d-arabinofuranosyl/-pyrimidine nucleosides
JPH0725785B2 (ja) アデノシン誘導体及び該化合物を有効成分として含有する医薬組成物
JP3204972B2 (ja) 新規サリドマイド誘導体、その製造方法並びにこれを薬剤として使用する方法
JPH02178272A (ja) 新規な２’―ハロメチリデン、２’―エテニリデン及び２’―エチニルシチジン、ウリジン及びグアノシン誘導体類
WO2001034162A1 (fr) Compositions anti-vih
JPH05509307A (ja) プリンの抗ウイルス性ホスホノ―アルケン誘導体
JPH06511230A (ja) ６，９−ビス（置換アミノ）ベンゾ〔ｇ〕イソキノリン−５，１０−ジオン類
WO1992009611A1 (en) Pharmaceuticals
JPH02160769A (ja) 新規な２′―ハロメチリデン、２′―エテニリデン及び２′―エチニルアデノシン誘導体類
JPH07504666A (ja) プリン類似化合物の抗ウイルス性ホスホン酸誘導体
JP2009532497A5 (enExample)
JPH04202185A (ja) ピペラジン誘導体及びこれを含有する医薬製剤
JPS61171490A (ja) グリセリルホスホリルコリンのジアシル誘導体
DE3814057A1 (de) 6-oxo-pyridazinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US5013829A (en) Stable congener of 2',3'-dideoxyadenosine
JPH02286682A (ja) 新規化合物、その製法及びそれを含む医薬組成物
DE3709699C2 (de) 5-Fluoruracil-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
JPH08501289A (ja) 抗腫瘍薬としての新規メタロセン（ｍｅｔａｌｌｏｃｅｎｅｓ）
CA2170155A1 (en) Tris(substituted phenyl)bismuth derivatives
JPS63287794A (ja) エンド‐ビシクロ〔２．２．１〕ヘプチルアデノシンの個々の異性体
EP1465876B1 (en) Long chain fatty alcohol substituents in antineoplastic agents